Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02392247 · ClinicalTrials.gov registry record
Hemosonics- VCU Cardiac Surgery Clinical Study
A clinical trial, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- 52
- Enrollment target
NCT02392247: Completed study, sponsored by Virginia Commonwealth University.
NCT02392247 is a clinical trial that has completed, run by Virginia Commonwealth University. The registered enrollment target is 52 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02392247 has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- 52 participants
- Enrollment target
Study Summary
This study compares the results of current standard coagulation measurement devices to the Quantra System, a new device, using small amount of extra blood obtained during routine blood draws in cardiac surgery patients.
Primary Outcome
Coagulation Function assessed at 4 time points \[baseline, during bypass, 10 minutes after heparin reversal just prior to bypass weaning, and off-bypass before transfer to the ICU\] over the course of cardiac surgery until patient ICU transfer
Interventions
- DEVICE Coagulation function
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2015-04 |
| Est. Completion | 2015-09 |
What the finished NCT02392247 record still lists
NCT02392247 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 52 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Coagulation function is the first listed.
NCT02392247 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02392247 about?
NCT02392247 is a clinical study titled "Hemosonics- VCU Cardiac Surgery Clinical Study". This study compares the results of current standard coagulation measurement devices to the Quantra System, a new device, using small amount of extra blood obtained during routine blood draws in cardiac surgery patients.
What is the current status of trial NCT02392247?
This trial is currently completed. The enrollment target is 52 participants. The study started on 2015-04. Estimated completion is 2015-09.
What interventions are being tested in trial NCT02392247?
The interventions under investigation include: Coagulation function (DEVICE).
Who is sponsoring clinical trial NCT02392247?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02630121 · 52 participants · Phase 4
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
- NCT03629171 · 52 participants · Phase 2
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
- NCT04128748 · 52 participants · Phase 1
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
- NCT04150497 · 52 participants · Phase 1
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia